Article metrics

Type I interferon blockade with anifrolumab in patients with systemic lupus erythematosus modulates key immunopathological pathways in a gene expression and proteomic analysis of two phase 3 trials

 

Online download statistics by month:

Online download statistics by month: April 2024 to June 2024

AbstractFullPdf
Apr 202417471637822
May 202422742230766
Jun 202410271001382
Total504848681970